Ocrelizumab (Anti-CD20)
Ocrelizumab (Anti-CD20) is a recombinant humanized monoclonal IgG1 antibody that selectively targets CD20 antigen present on B-cells. It is used to treat relapsing remitting multiple sclerosis. MW:145.5 KD.
| Catalog Number | A2561 |
| CAS# | 637334-45-3 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/ocrelizumab-anti-cd20.html |